Molecular Assessment for Gastro-Esophageal Cancer

NARecruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

July 1, 2029

Study Completion Date

July 1, 2029

Conditions
Esophageal CancerGastric CancerBarrett Esophagus
Interventions
DIAGNOSTIC_TEST

Breath analysis

Detection of proteins and volatile organic compounds (oncometabolites) in the exhaled breath

DIAGNOSTIC_TEST

Blood analysis

Detection of proteins and circulating tumor DNA (oncometabolites) in the peripheral blood

Trial Locations (1)

3000

RECRUITING

University Hospitals Leuven, Leuven

All Listed Sponsors
lead

KU Leuven

OTHER